Induction and consolidation with daratumumab (Darzalex), lenalidomide (Revlimid), and carfilzomib (Kyprolis) plus dexamethasone (Dara-KRd) followed by daratumumab/lenalidomide maintenance exhibited prolonged progression-free survival (PFS) in…
Dara-KRd Regimen Displays Prolonged PFS in Newly Diagnosed Multiple Myeloma
